RIYADH, Saudi Arabia — Hevolution Foundation, a global non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, announces that it is providing $5 Million in matching funding to Impetus Grants, a non-profit science funding organization focused on longevity research. The Rosenkranz Foundation, founded by Robert Rosenkranz, chairman of Delphi Capital Management, has also pledged $5 Million, for a total contribution of $10 Million.
“Following our matching funding for Impetus Grants last summer, we are pleased to partner with the organization once again,” commented Dr. Mehmood Khan, Chief Executive Officer of Hevolution Foundation. “We are confident that this program will help advance the boundaries of aging science and pave the way for transformative discoveries.”
The initiative aims to contribute to the acceleration of scientific breakthroughs in the aging research space and to help extend human healthspan. This pledge builds on Hevolution’s $2 Million in matching funds for Impetus Grants, to support 14 research projects, announced in August 2022. A list of recipients is available here.
Information about applying for funding under this new program will be available on the Impetus Grants website starting on August 1, 2023.
